AJCP CME: Diagnostic Challenges in Pathologic Staging of Renal Cell Carcinoma Following Systemic Immunotherapy

This AJCP article offers 1.0 continuing education (CME) credit that can be used to fulfill CC Part II requirements. Purchase of this CME activity provides gratis access to a PDF of the journal article for the learner’s personal use only.

Write a Review

List Price: $25.00
Member Price: $19.00

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $6.00 or more

Join

Item Details:

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, learners will be able to:

List the typical histological changes that may be observed in resection renal carcinoma specimens following immune-checkpoint inhibitor treatment.

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, learners will be able to:

List the typical histological changes that may be observed in resection renal carcinoma specimens following immune-checkpoint inhibitor treatment.
Summarize the impact of comparing pathological size and stage of carcinomas following checkpoint-inhibitor treatment with pre-treatment radiology.
Outline the current recommendations of the International Neoadjuvant Kidney Cancer Consortium (INKCC) regarding pathological examination of resected renal carcinoma specimens, and discuss current gaps in knowledge regarding examination and staging after treatment.

View More View Less

AJCP CME: Diagnostic Challenges in Pathologic Staging of Renal Cell Carcinoma Following Systemic Immunotherapy

Item Details:

Bought This Bought That ...